搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
sanofi
4 小时
Press Release: ASH: Sarclisa combinations demonstrated significant benefits in newly ...
ASH: Sarclisa combinations demonstrated significant benefits in newly diagnosed multiple myeloma patients New analysis from the IMROZ phase 3 study of Sarclisa-VRd demonstrated higher and ...
precisionmedicineonline
7 小时
BioArctic Doses First Parkinson's Patient in Trial of Alpha-Synuclein-Targeting Drug
Exidavnemab is a monoclonal antibody designed to eliminate aggregated clumps of the protein biomarker and slow progression of Parkinson's disease.
9 小时
AbbVie Says Phase 3 TEMPO-2 Study Of Tavapadon In Early Parkinson's Disease Met Main Goal
Monday said Phase 3 TEMPO-2 study evaluating tavapadon in early Parkinson's disease met its primary goal. In the ...
edexec.co.uk
10 小时
Parkinson’s Law
We here at EdExec pride ourselves in creating solutions for suppliers to deliver their message in the most effective and ...
edexec.co.uk
13 小时
Mastering Parkinson’s Law for Better Project Planning
Explore the concept of Parkinson’s Law and learn how setting realistic deadlines can help you manage your tasks more ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈